-
News: Amendment to UK Patent Act provides further exception to patent infringement
News and Views: Clinical Investigation
-
News: Amendment to UK Patent Act provides further exception to patent infringement
News and Views: Clinical Investigation
-
News: Amendment to UK Patent Act provides further exception to patent infringement
News and Views: Clinical Investigation
-
News: Amendment to UK Patent Act provides further exception to patent infringement
News and Views: Clinical Investigation
-
News: Amendment to UK Patent Act provides further exception to patent infringement
News and Views: Clinical Investigation
-
News: Amendment to UK Patent Act provides further exception to patent infringement
News and Views: Clinical Investigation
-
News: Amendment to UK Patent Act provides further exception to patent infringement
News and Views: Clinical Investigation
-
News: Amendment to UK Patent Act provides further exception to patent infringement
News and Views: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Pediatric trials of antihypertensive agents: impact of trial design and unique pediatric factors on efficacy end points
Kevin D Hill, Patricia Y Chu, Jennifer S Li & Christoph P Hornik
Clinical Trail Methodology: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer
Kouji Izumi, Lei Li & Chawnshang Chang
Clinical Trail Outcomes: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Challenges in clinical trial design for recurrent glioblastoma
Katharine A McNeill, Howard A Fine
Clinical Trail Methodology: Clinical Investigation
-
Genetic biomarkers of placebo response: what could it mean for future trial design?
Kathryn T Hall & Ted J Kaptchuk
Editorial: Clinical Investigation
-
Genetic biomarkers of placebo response: what could it mean for future trial design?
Kathryn T Hall & Ted J Kaptchuk
Editorial: Clinical Investigation
-
Genetic biomarkers of placebo response: what could it mean for future trial design?
Kathryn T Hall & Ted J Kaptchuk
Editorial: Clinical Investigation
-
Genetic biomarkers of placebo response: what could it mean for future trial design?
Kathryn T Hall & Ted J Kaptchuk
Editorial: Clinical Investigation
-
Genetic biomarkers of placebo response: what could it mean for future trial design?
Kathryn T Hall & Ted J Kaptchuk
Editorial: Clinical Investigation
-
Genetic biomarkers of placebo response: what could it mean for future trial design?
Kathryn T Hall & Ted J Kaptchuk
Editorial: Clinical Investigation
-
Genetic biomarkers of placebo response: what could it mean for future trial design?
Kathryn T Hall & Ted J Kaptchuk
Editorial: Clinical Investigation
-
Genetic biomarkers of placebo response: what could it mean for future trial design?
Kathryn T Hall & Ted J Kaptchuk
Editorial: Clinical Investigation